Access cutting-edge liver cirrhosis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access liver cirrhosis specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cirrhosis treatment provided free
This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Check if you qualify for this liver cirrhosis clinical trial in New York, NY
If you're searching for liver cirrhosis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cirrhosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.